Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Natural killer cell Stories

2014-03-25 08:30:19

Modified MIC Proteins as Targeted Immunotherapy for Cancer and Virus-Infected Cells SOUTH SAN FRANCISCO, Calif., March 25, 2014 /PRNewswire/ -- AvidBiotics Corp., a privately held biotechnology company developing novel, non-antibody proteins targeting cancer and virus-infected cells, today announced that it has received an issued patent from the U.S. Patent and Trademark Office covering the targetable immunotherapeutic platform being developed by the company. US Patent No....

2013-12-09 12:25:49

- Preclinical Research with Novel, Highly Specific Mouse anti-iNKT Antibodies Presented at American Society of Hematology Meeting WALTHAM, Mass., Dec. 9, 2013 /PRNewswire/ -- NKT Therapeutics (NKTT) today presented research results with NKT14 and NKT14m, monoclonal antibodies designed to deplete (NKT14) or activate (NKT14m) murine iNKT cells. The results from these studies demonstrate that NKT14 can produce a complete and long lasting depletion of both peripheral blood and tissue...

2013-06-06 23:44:00

Next Generation Choices Foundation (Lesscancer.org ) Mourns the Loss of board member Ronald B. Herberman, M.D. renown physician and scientist. Rye, New Hampshire (PRWEB) June 05, 2013 Steve Twedt of the Pittsburgh Post-Gazette reported yesterday morning, Ronald B. Herberman,M.D., the founding director of the University of Pittsburgh Cancer Institute, died unexpectedly this past weekend. Herberman, 72, died June 1. He is survived by his wife, Harriett, and his children, Holly and Steven. A...

2013-04-30 08:33:24

Compounds enhance immune function in mammals SANTA ROSA, Calif., April 30, 2013 /PRNewswire/ -- The United States Patent and Trademark Office has awarded Isaac Eliaz, M.D., patent # 8,426,567, on April 23, 2013 for modified citrus pectin (MCP) and modified alginates as: "A method for enhancing mammalian immunological function." Specifically, the patent recognizes that MCP and modified alginate help improve the immune response in mammals, particularly humans. "I am very excited that...

Cancer Cells' Achilles' Heel Revealed In Video
2013-04-24 13:47:47

University of Manchester [ Watch The Video Cancerous B Cell Being Destroyed by Natural Killer Cells ] Scientists from the Manchester Collaborative Centre for Inflammation Research (MCCIR) have discovered why a particular cancer drug is so effective at killing cells. Their findings could be used to aid the design of future cancer treatments. Professor Daniel Davis and his team used high quality video imaging to investigate why the drug rituximab is so effective at killing cancerous B...

2012-11-26 11:21:26

-People with a type of brain tumor called glioblastoma live 12 months on average, so new forms of treatment for this malignancy are badly needed. -Viruses designed to kill cancer cells offer a safe way to treat these tumors, but the therapy doesn't work as well as expected. -This study found that a patient's immune system tries to eliminate the anticancer virus and blocking this immune activity gave the virus more time to kill cancer cells. Doctors now use cancer-killing viruses to treat...

Scientists Learn How To Unlock The Destiny Of A Cell
2012-11-01 10:47:17

University of California - Santa Barbara Scientists have discovered that breaking a biological signaling system in an embryo allows them to change the destiny of a cell. The findings could lead to new ways of making replacement organs. The discovery was made in the laboratory of Joel H. Rothman, a professor in the Department of Molecular, Cellular, and Developmental Biology at UC Santa Barbara. The studies were reported in the interdisciplinary journal Genes and Development, and were...

2012-10-11 04:04:09

Frozen, Thaw-and-Use Cells Reduce Variability Compared to PBMCs and NK Cells Madison, WI (PRWEB) October 10, 2012 Promega Corporation announces the introduction of a novel bioluminescent assay for the quantification of Fc effector function of antibody-based molecules in the development and manufacture of biologic drugs. The assay is ADCC mechanism of action (MOA)-based and features frozen, thaw-and-use effector cells, and optimized reagents and protocol to perform a reporter-based ADCC...

2012-06-11 20:07:02

The human immune system has a natural ability to identify and attack tumor cells. Natural killer (NK) cells are innate immune cells that are particularly effective at killing tumor cells due to their ability to secrete cytotoxic enzymes. However, mutations have allowed many types of tumors to develop a resistance to NK-mediated killing through ill-defined mechanisms. Dr. Jerome Ritz and colleagues at the Dana-Farber Cancer Institute in Boston sought to pinpoint some of these mechanisms using...

2012-03-02 05:53:04

(Ivanhoe Newswire) — Good news! Researchers have discovered a promising new technique that potentially could turn immune system killer T cells into more effective weapons against infections and possibly cancer. “The technique involves delivering DNA into the immune system's instructor cells. The DNA directs these cells to overproduce a specific protein that jumpstarts important killer T cells, called CD8 T cells. These killer cells are typically repressed in patients who have...